In this episode of Fat Science, hosts Dr. Emily Cooper, Andrea Taylor, and Mark Wright explore the compelling and urgent topic of COVID-19's impact on metabolic health.

COVID-19 has introduced a serious new layer of complexity because it can exacerbate existing conditions like diabetes, obesity, cardiovascular and thyroid disease. 

The latest data reveal a shocking statistic—the risk of developing diabetes can increase by up to 40 percent after a COVID infection. 

So what should we know about these risks, and how can scientific insight help us navigate this new terrain?

Key Discussion Points:

• Early Data and Predictions: Insights from Dr. Cooper's clinic, supported by the Diabesity Institute, which identified early links between COVID-19 and metabolic disease risk.


• Real-World Impacts: The clinic’s database comprising around 2,500 patients with more than 10 years of data, which showcases the regression of metabolic health progress post-pandemic.


• Public Health: The importance of vaccinations, continuous COVID monitoring, and preventive practices to mitigate these risks.


• Metabolic Meds: The role of medications like Metformin and Ozempic in managing complications from pre-diabetes and diabetes, particularly during COVID.

Resources:

• Connect with Dr. Emily Cooper on LinkedIn.


• Connect with Mark Wright on LinkedIn.


• Connect with Andrea Taylor on Instagram.

Fat Science is a podcast on a mission to explain where our fat really comes from and why it won’t go and stay away. In each episode, we share little-known facts and personal experiences to dispel misconceptions, reduce stigma, and instill hope. 

Fat Science is committed to creating a world where people are empowered with accurate information about metabolism and recognize that fat isn’t a failure. This podcast is for informational purposes only and is not intended to replace professional medical advice.

If you have a question for Dr. Cooper, a show idea, feedback, or just want to connect, email us at info@diabesityinstitute.org.